About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye

NCT00832130·11 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

TearScience, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

At least 18 years of age.
Meibomian gland obstruction
Dry eye symptoms
Willingness to comply with study procedures and return for all visits

You may not be if

Ocular surgery, injury, or herpes infection within past 3 months
Active ocular infection
Active ocular inflammation or recurrent inflammation within past 3 months
Moderate to severe allergic conjunctivitis
Severe eyelid inflammation
Eyelid abnormalities that affect lid function
Ocular surface abnormalities that may compromise corneal integrity
Macular disease
Systemic disease condition or medication that causes dry eye
Use of other treatments for meibomian gland dysfunction or dry eye
Pregnant or nursing women
Participation in another ophthalmic clinical trial within past 30 days

The record

StatusCompleted

PhaseNo phase

Taking part139

StartedFeb 2009

UpdatedDec 12, 2011

Conditions

Chalazion Dry Eye Syndromes

Where11

Fayetteville, Arkansas, United States
Morrow, Georgia, United States
Highland Park, Illinois, United States

Clareo Health | Treatment of Meibomian Gland Dysfunction and Evaporative Dry Eye